TNYA: Tenaya Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 356.47
Enterprise Value ($M) 310.79
Book Value ($M) 139.42
Book Value / Share 1.78
Price / Book 2.56
NCAV ($M) 80.49
NCAV / Share 1.03
Price / NCAV 4.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.82
Return on Assets (ROA) -0.51
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 4.91
Current Ratio 4.91

Balance Sheet (mrq) ($M)
Current Assets 111.58
Assets 170.51
Liabilities 31.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -131.19
Net Income -124.08

Cash Flow Statement (mra) ($M)
Cash From Operations -102.07
Cash from Investing 48.72
Cash from Financing 4.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-22 13D/A Beehouse, LLC 15.92 -13.31
02-14 13G/A Rtw Investments, Lp 0.00 -100.00
02-14 13G/A Price T Rowe Associates Inc /md/ 6.70 1.62
02-14 13D/A Column Group Iii, Lp 17.70 19.60
02-14 13G/A Ra Capital Management, L.p. 9.99 8.09
01-31 13G BlackRock Inc. 5.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 31,290 127,190 24.60
2024-04-30 14,202 132,298 10.73
2024-04-29 22,462 46,772 48.02
2024-04-26 9,670 48,413 19.97

(click for more detail)

Similar Companies
TECH – Bio-Techne Corporation TERN – Terns Pharmaceuticals, Inc.
TLRY – Tilray Brands, Inc. TRML – Tourmaline Bio, Inc.
TSHA – Taysha Gene Therapies, Inc.


Financial data and stock pages provided by
Fintel.io